Drug Enforcement Administration November 17, 2022 – Federal Register Recent Federal Regulation Documents

Schedules of Controlled Substances: Placement of Amineptine in Schedule I
Document Number: 2022-25003
Type: Rule
Date: 2022-11-17
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Drug Enforcement Administration places amineptine (chemical name: 7-[(10,11-dihydro-5H- dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. This action is being taken to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle amineptine.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.